MORGAN STANLEY - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,480,309
-63.0%
2,913,784
-0.2%
0.00%
-66.7%
Q2 2023$31,051,038
+27.5%
2,921,076
-0.1%
0.00%0.0%
Q1 2023$24,361,318
+7.6%
2,924,528
+19.2%
0.00%0.0%
Q4 2022$22,647,523
-32.5%
2,453,686
-6.1%
0.00%
-40.0%
Q3 2022$33,538,000
-2.9%
2,612,042
-0.1%
0.01%
+25.0%
Q2 2022$34,556,000
-35.7%
2,615,874
+2.5%
0.00%
-42.9%
Q1 2022$53,722,000
+1711.3%
2,552,129
+1964.7%
0.01%
Q4 2021$2,966,000
-17.7%
123,610
-12.8%
0.00%
Q3 2021$3,606,000
-44.9%
141,725
-27.1%
0.00%
-100.0%
Q2 2021$6,548,000
-22.3%
194,490
-10.3%
0.00%0.0%
Q1 2021$8,426,000
+1140.9%
216,935
+1878.6%
0.00%
Q4 2020$679,000
+565.7%
10,964
+257.7%
0.00%
Q3 2020$102,000
-91.5%
3,065
-93.9%
0.00%
Q2 2020$1,206,000
+930.8%
50,590
+891.8%
0.00%
Q1 2020$117,000
-76.4%
5,101
-70.8%
0.00%
Q4 2019$496,000
+281.5%
17,499
+189.7%
0.00%
Q3 2019$130,000
+25.0%
6,040
+70.1%
0.00%
Q2 2019$104,0003,5500.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders